Title of Collaborative Activity: |
Endocrinologic and Metabolic Drugs Advisory Committee |
Description of Collaborative Activity: |
The Endocrinologic and Metabolic Drugs Advisory Committee (the Committee) advises the Commissioner or designee in discharging responsibilities as they relate to helping to ensure safe and effective drugs for human use and, as required, any other product for which the Food and Drug Administration (FDA) has regulatory responsibility. |
Type of Collaborative Activity: |
Committee, Advisory Group, or Work Group
|
Year the Collaborative Activity Originated: |
|
NIH Participating Institutes/Centers/Office of the Director: |
NICHD |
HHS Agency Collaborators on this Activity: |
FDA |
